Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

7 Feb 2013 07:00

RNS Number : 3162X
Avon Rubber PLC
06 February 2013
 



Strictly embargoed until 07:00 Thursday 7 February 2013

 

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 OCTOBER 2012 TO 6 FEBRUARY 2013

 

Introduction

The financial year has started positively and the investments we have made and continue to make in innovative new products and to gain access to new markets have positioned us well to deliver further growth this year.

 

Protection & Defence

In Protection & Defence an improved order book was carried forward into this financial year and included the £14.7m Middle Eastern order announced in May 2012. This has resulted in a stronger first quarter performance compared to the previous year.

 

We have delivered M50 mask systems to the US Department of Defense (DoD) at a similar rate to 2012 and, despite continued uncertainty, we believe that we are well positioned and should not be significantly impacted by US Government cuts in the defence budget. We already have orders in hand for mask systems through to the end of our third quarter. As expected, we delivered 130,000 pairs of M61 filters during the period. We also secured orders for a further 100,000 pairs which we expect to deliver in our second quarter. So far sales to the US homeland security and first responder markets have been significantly stronger than in 2012.

 

Our first new product under Project Fusion was launched during the quarter. The PC50 is an air purifying respirator targeted specifically at the US correctional facilities market. Project Fusion as a whole, which is expected to deliver further organic growth from 2014, remains on track.

 

Dairy

The Milkrite ImpulseAir mouthpiece vented liner continues to perform well and we have seen further quarter on quarter sales growth at our newly established Chinese operation.

 

In other markets lower milk prices and higher feed costs in our traditional markets have reduced farmer revenues and margins, leading to fluctuating demand for our consumable products in the first quarter of our financial year. Planned new product introductions should provide opportunities for growth in the remainder of the year.

 

 

Net debt

The Group's balance sheet remains robust with net debt at 31 December 2012 at £10.1m (30 September 2012: £8.7m) due to the timing of working capital movements and the £1.8m of funding provided to the Employee Share Ownership Trusts to fund the purchase of the Company's shares for awards under the Performance Share Plan. 

 

 

Board changes

As previously announced Sir Richard Needham will retire as a Director at the conclusion of today's Annual General Meeting.

 

Outlook

Given the positive start to the year, the Board is confident of meeting full year market expectations, despite the challenges provided by the uncertain economic and political environment, particularly in the US.

 

Half Year announcement

The Group will announce its results for the half year to 31 March 2013 on Wednesday 1st May 2013.

 

For further enquiries, please contact:

 

 

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896831

Andrew Lewis, Group Finance Director

01225 896830

Miles Ingrey-Counter, Company Secretary

01225 896850

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

 

NOTES TO EDITORS: Avon is focused on two specialist areas - Protection & Defence and Dairy

With over 120 years' experience, Avon Rubber p.l.c. is an innovative design and engineering group specialising in two core markets, Protection & Defence and Dairy. With a strong emphasis on research and development, we design, test and manufacture specialist products from a number of sites in the US and the UK, serving markets around the world.

Avon Protection is the recognised global market leader in advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection system technology. Our unrivalled 80 year pedigree in military mask design and manufacture has placed Avon Protection's products at the heart of many international defence and tactical Personal Protective Equipment (PPE) deployment strategies. Our expanding global customer base now includes military forces, civil and first line defence troops, emergency service teams and industrial, marine, mineral and oil extraction site personnel. All put their trust in Avon's advanced respiratory solutions.

Our world leading Dairy business and its Milkrite brand have a global market presence. Our unique designs and innovative technology are described by one particular customer as "the biggest advance in the milking process in a generation". Working with the leading scientists and health specialists in the industry, we continue to invest in technology to further improve the milking process and animal welfare. As our market share and milking experience continues to grow so does our global presence.

For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSFFAMFDSESE
Date   Source Headline
21st Mar 20194:00 pmRNSDirector/PDMR Shareholding
14th Mar 20192:01 pmRNSHolding(s) in Company
6th Mar 20194:00 pmRNSDirector/PDMR Shareholding
21st Feb 201912:00 pmRNSHolding(s) in Company
8th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 201910:00 amRNSResult of AGM
1st Feb 20197:00 amRNSU.S. Department of Defense M69 Aircrew Mask Orders
31st Jan 20197:00 amRNSAnnual General Meeting - Trading Update
9th Jan 20194:00 pmRNSDirector/PDMR Shareholding
7th Jan 20197:00 amRNSUS Department of Defense M69 Aircrew Mask Contract
11th Dec 201812:00 pmRNSDirector/PDMR Shareholding
5th Dec 20184:00 pmRNSDirector/PDMR Shareholding
4th Dec 20183:00 pmRNSDirector/PDMR Shareholding
30th Nov 201812:00 pmRNSNotice of Annual Report and Accounts and AGM
14th Nov 20184:26 pmRNSDirector/PDMR Shareholding
14th Nov 20187:00 amRNSFinal Results
5th Nov 20183:48 pmRNSDirector/PDMR Shareholding
5th Oct 20184:06 pmRNSDirector/PDMR Shareholding
17th Sep 20183:07 pmRNSDirector/PDMR Shareholding
14th Sep 20187:00 amRNSPre-close trading update
6th Sep 201811:33 amRNSDirector/PDMR Shareholding
8th Aug 201810:26 amRNSDirector/PDMR Shareholding
26th Jul 20184:29 pmRNSDirector/PDMR Shareholding
26th Jul 20182:59 pmRNSDirector/PDMR Shareholding
17th Jul 20187:30 amRNSUS DoD M50 Mask Systems Order
6th Jul 20189:24 amRNSDirector/PDMR Shareholding
8th Jun 20189:24 amRNSHolding(s) in Company
5th Jun 20183:01 pmRNSDirector/PDMR Shareholding
30th May 20182:55 pmRNSDirector/PDMR Shareholding
18th May 201812:11 pmRNSDirector/PDMR Shareholding
16th May 20182:57 pmRNSDirector/PDMR Shareholding
8th May 20183:45 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNSHalf-year Report
6th Apr 20189:54 amRNSDirector/PDMR Shareholding
3rd Apr 20187:00 amRNSDisposal
13th Mar 20187:00 amRNSCapital Markets Event
5th Mar 20184:19 pmRNSDirector/PDMR Shareholding
23rd Feb 20184:17 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSHolding(s) in Company
15th Feb 20187:00 amRNSUK MoD General Service Respirator Agreement
14th Feb 20185:13 pmRNSHolding(s) in Company
7th Feb 20185:30 pmRNSHolding(s) in Company
5th Feb 20184:13 pmRNSDirector/PDMR Shareholding
1st Feb 20183:58 pmRNSResult of AGM
1st Feb 20187:00 amRNSAGM Statement
29th Jan 20187:00 amRNSUS Department of Defense Mask Systems Order
24th Jan 20185:38 pmRNSHolding(s) in Company
24th Jan 201811:44 amRNSHolding(s) in Company
9th Jan 20188:52 amRNSDirector/PDMR Shareholding
20th Dec 201712:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.